ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Postoperative Consequences of Intraoperative NOL Titration

ClinicalTrials.gov ID: NCT04679818

Public ClinicalTrials.gov record NCT04679818. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 5:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT04679818
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
The Cleveland Clinic
Other
Enrollment
72 participants

Conditions and interventions

Interventions

  • PMD-200 Nol-guided opioid administration Device
  • Routine opioid management Drug

Device · Drug

Eligibility (public fields only)

Age range
21 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 29, 2020
Primary completion
Dec 29, 2022
Completion
Jan 9, 2023
Last update posted
Jun 20, 2024

2020 – 2023

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Cleveland Clinic Cleveland Ohio 44195

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04679818, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 20, 2024 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04679818 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →